Skip to main content
SpringerLink
Log in
Book cover

Obstetric and Gynecologic Nephrology pp 61–76Cite as

Renal Manifestations in Lupus Pregnancy

  • Chapter
  • First Online:

  • 679 Accesses

Abstract

The management of pregnancy in patients with SLE, lupus nephritis, and APS is complex and should start well before conception by evaluating maternal and fetal risks and medication adjustment. Interdisciplinary collaboration between the rheumatologist, nephrologist, and high-risk obstetrician is very important, and a careful treatment plan has to be drafted with close monitoring by involved specialties throughout the course of pregnancy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol. 2005;32(9):1709–12.

    PubMed  Google Scholar 

  2. Clowse ME, Magder LS, Petri M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol. 2011;38(6):1012–6.

    Article  CAS  PubMed  Google Scholar 

  3. Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med. 2015;163(3):153–63.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum. 2012;64(7):2311–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Yan Yuen S, Krizova A, Ouimet JM, Pope JE. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review. Open Rheumatol J. 2008;2:89–98.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52(2):514–21.

    Article  PubMed  Google Scholar 

  7. Gregory EC, MacDorman MF, Martin JA. Trends in fetal and perinatal mortality in the United States, 2006–2012. NCHS Data Brief. 2014;(169):1–8.

    Google Scholar 

  8. Arkema EV, Palmsten K, Sjöwall C, Svenungsson E, Salmon JE, Simard JF. What to expect when expecting with systemic lupus erythematosus (SLE): a population-based study of maternal and fetal outcomes in SLE and pre-SLE. Arthritis Care Res (Hoboken). 2016;68(7):988–94.

    Article  Google Scholar 

  9. Mintz G, Niz J, Gutierrez G, Garcia-Alonso A, Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986;13(4):732–9.

    CAS  PubMed  Google Scholar 

  10. Yang H, Liu H, Xu D, Zhao L, Wang Q, Leng X, et al. Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares – a case control study. PLoS One. 2014;9(8):e104375.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Chakravarty EF, Colon I, Langen ES, Nix DA, El-Sayed YY, Genovese MC, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192(6):1897–904.

    Article  PubMed  Google Scholar 

  12. Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus. 2005;14(1):89–94.

    Article  CAS  PubMed  Google Scholar 

  13. Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin N Am. 2007;33(2):237–52.. v

    Article  Google Scholar 

  14. Ko HS, Ahn HY, Jang DG, Choi SK, Park YG, Park IY, et al. Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE. Int J Med Sci. 2011;8(7):577–83.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun. 2016;74:6–12.

    Article  PubMed  Google Scholar 

  16. Doria A, Iaccarino L, Sarzi-Puttini P, Ghirardello A, Zampieri S, Arienti S, et al. Estrogens in pregnancy and systemic lupus erythematosus. Ann N Y Acad Sci. 2006;1069:247–56.

    Article  CAS  PubMed  Google Scholar 

  17. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 2006;22(2):234–41.

    Article  CAS  PubMed  Google Scholar 

  18. Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004;13(9):635–8.

    Article  CAS  PubMed  Google Scholar 

  19. de Jesus GR, Mendoza-Pinto C, de Jesus NR, Dos Santos FC, Klumb EM, Carrasco MG, et al. Understanding and managing pregnancy in patients with lupus. Autoimmune Dis. 2015;2015:943490.

    PubMed  PubMed Central  Google Scholar 

  20. Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016;214(1):108 e1–e14.

    Article  CAS  Google Scholar 

  21. Leaños-Miranda A, et al. Circulating angiogenic factors and the risk of preeclampsia in systemic lupus erythematosus pregnancies. J Rheumatol. 2015;42(7):1141–9.

    Article  PubMed  CAS  Google Scholar 

  22. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

    Article  CAS  PubMed  Google Scholar 

  23. Chighizola CB, Gerosa M, Trespidi L, Di Giacomo A, Rossi F, Acaia B, et al. Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome. Expert Rev Clin Immunol. 2014;10(11):1505–17.

    Article  CAS  PubMed  Google Scholar 

  24. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011;7(6):330–9.

    Article  CAS  PubMed  Google Scholar 

  25. Salmon JE, Girardi G, Lockshin MD. The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nat Clin Pract Rheumatol. 2007;3(3):140–7; quiz 1 p following 87.

    Article  CAS  PubMed  Google Scholar 

  26. Bertolaccini ML, Sanna G. Recent advances in understanding antiphospholipid syndrome. F1000Res. 2016;5:2908.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Proulle V, Furie RA, Merrill-Skoloff G, Furie BC, Furie B. Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. Blood. 2014;124(4):611–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Borella E, Lojacono A, Gatto M, Andreoli L, Taglietti M, Iaccarino L, et al. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res. 2014;60(2–3):170–6.

    Article  CAS  PubMed  Google Scholar 

  29. Saavedra MA. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol. 2012;31(5 SRC - GoogleScholar):813–9.

    Article  PubMed  Google Scholar 

  30. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5(11):2060–8.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Bramham K, Hunt BJ, Bewley S, Germain S, Calatayud I, Khamashta MA, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011;38(9):1906–13.

    Article  PubMed  Google Scholar 

  32. Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun. 2016;74:194–200.

    Article  PubMed  Google Scholar 

  33. Wagner SJ, Craici I, Reed D, Norby S, Bailey K, Wiste HJ, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009;18(4):342–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Smyth A, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin Soc Nephrol p. 2010;5(11 SRC – GoogleScholar):2060–8.

    Article  Google Scholar 

  35. Moroni G. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. 2016;74SRC – GoogleScholar:6–12.

    Google Scholar 

  36. Andrade R, Sanchez ML, Alarcon GS, Fessler BJ, Fernandez M, Bertoli AM, et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected]. Clin Exp Rheumatol. 2008;26(2):268–74.

    CAS  PubMed  Google Scholar 

  37. Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol. 2003;16(2):161–7.

    PubMed  Google Scholar 

  38. Carmona F, Font J, Moga I, Lazaro I, Cervera R, Pac V, et al. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol. 2005;53(4):182–8.

    Article  PubMed  Google Scholar 

  39. Ritchie J, Smyth A, Tower C, Helbert M, Venning M, Garovic V. Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus. 2012;21(5):534–41.

    Article  CAS  PubMed  Google Scholar 

  40. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019–27.

    Article  PubMed  Google Scholar 

  41. Opatrny L, David M, Kahn SR, Shrier I, Rey E. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol. 2006;33(11):2214–21.

    CAS  PubMed  Google Scholar 

  42. Sinico RA, Cavazzana I, Nuzzo M, Vianelli M, Napodano P, Scaini P, et al. Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol. 2010;5(7):1211–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Nochy D, Daugas E, Droz D, Beaufils H, Grunfeld JP, Piette JC, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999;10(3):507–18.

    CAS  PubMed  Google Scholar 

  44. Tektonidou MG. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin Rev Allergy Immunol. 2009;36(2–3):131–40.

    Article  CAS  PubMed  Google Scholar 

  45. Fakhouri F. Pregnancy-related thrombotic microangiopathies: clues from complement biology. Transfus Apher Sci. 2016;54(2):199–202.

    Article  PubMed  Google Scholar 

  46. George JN, Nester CM, McIntosh JJ. Syndromes of thrombotic microangiopathy associated with pregnancy. Hematology Am Soc Hematol Educ Program. 2015;2015:644–8.

    Article  PubMed  Google Scholar 

  47. Thomas MR, Robinson S, Scully MA. How we manage thrombotic microangiopathies in pregnancy. Br J Haematol. 2016;173(6):821–30.

    Article  PubMed  Google Scholar 

  48. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7.

    Article  PubMed  Google Scholar 

  49. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ. 2013;347:f6564.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Marchetti T, de Moerloose P, Gris JC. Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control study. J Thromb Haemost. 2016;14(4):675–84.

    Article  CAS  PubMed  Google Scholar 

  51. Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, et al. Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med. 2016;3(1):e000131.

    Article  PubMed  PubMed Central  Google Scholar 

  52. do Prado AD, Piovesan DM, Staub HL, Horta BL. Association of anticardiolipin antibodies with preeclampsia. Obstet Gynecol. 2010;116(6):1433–43.

    Article  PubMed  Google Scholar 

  53. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178(6):701–11.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Tedeschi SK, Guan H, Fine A, Costenbader KH, Bermas B. Organ-specific systemic lupus erythematosus activity during pregnancy is associated with adverse pregnancy outcomes. Clin Rheumatol. 2016;35(7):1725–32.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Yee CS, Akil M, Khamashta M, Bessant R, Kilding R, Giles I, et al. The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients. Rheumatology (Oxford). 2012;51(10):1877–80.

    Article  Google Scholar 

  56. Clowse ME, Wallace DJ, Weisman M, James A, Criscione-Schreiber LG, Pisetsky DS. Predictors of preterm birth in patients with mild systemic lupus erythematosus. Ann Rheum Dis. 2013;72(9):1536–9.

    Article  PubMed  Google Scholar 

  57. Ruiz-Irastorza G, Khamashta MA, Gordon C, Lockshin MD, Johns KR, Sammaritano L, et al. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum. 2004;51(1):78–82.

    Article  CAS  PubMed  Google Scholar 

  58. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford). 2002;41(6):643–50.

    Article  CAS  Google Scholar 

  59. Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009;24(2):519–25.

    Article  PubMed  Google Scholar 

  60. Shibata S, Sasaki T, Hirabayashi Y, Seino J, Okamura K, Yoshinaga K, et al. Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis. Ann Rheum Dis. 1992;51(5):619–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Moroni G, Quaglini S, Banfi G, Caloni M, Finazzi S, Ambroso G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis. 2002;40(4):713–20.

    Article  PubMed  Google Scholar 

  62. Clowse ME, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol. 2006;107(2 Pt 1):293–9.

    Article  PubMed  Google Scholar 

  63. Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76(3):476–85.

    Article  CAS  PubMed  Google Scholar 

  64. Fischer-Betz R, Specker C, Brinks R, Aringer M, Schneider M. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology (Oxford). 2013;52(6):1070–6.

    Article  CAS  Google Scholar 

  65. Gordon C. Pregnancy and autoimmune diseases. Best Pract Res Clin Rheumatol. 2004;18(3):359–79.

    Article  CAS  PubMed  Google Scholar 

  66. Espinosa G, Cervera R. Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol. 2015;11(10):586–96.

    Article  CAS  PubMed  Google Scholar 

  67. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64(6):797–808.

    Article  Google Scholar 

  68. Clowse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54(11):3640–7.

    Article  PubMed  Google Scholar 

  69. Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, Khamashta MA, Kim MY, Saxena A, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012;126(1):76–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology (Oxford). 2008;47(Suppl 3):iii9–12.

    Google Scholar 

  71. Armenti VT, Daller JA, Constantinescu S, Silva P, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation. Clin Transpl. 2006;20:57–70.

    Google Scholar 

  72. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71(8):1051–5.

    Article  CAS  PubMed  Google Scholar 

  73. Paziana K, Del Monaco M, Cardonick E, Moritz M, Keller M, Smith B, et al. Ciclosporin use during pregnancy. Drug Saf. 2013;36(5):279–94.

    Article  CAS  PubMed  Google Scholar 

  74. Webster P, Wardle A, Bramham K, Webster L, Nelson-Piercy C, Lightstone L. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus. 2014;23(11):1192–6.

    Article  CAS  PubMed  Google Scholar 

  75. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006;82(12):1698–702.

    Article  CAS  PubMed  Google Scholar 

  76. Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus. 2005;14(8):593–7.

    Article  CAS  PubMed  Google Scholar 

  77. Kart Köseoglu H, Yücel AE, Künefeci G, Ozdemir FN, Duran H. Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus. 2001;10(11):818–20.

    Article  PubMed  Google Scholar 

  78. Perricone R, De Carolis C, Kröegler B, Greco E, Giacomelli R, Cipriani P, et al. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford). 2008;47(5):646–51.

    Article  CAS  Google Scholar 

  79. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S–736S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford). 2002;41(8):924–9.

    Article  CAS  Google Scholar 

  81. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus. 2000;9(3):170–5.

    Article  CAS  PubMed  Google Scholar 

  82. Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368(23):2169–81.

    Article  CAS  PubMed  Google Scholar 

  83. Licht C, Greenbaum LA, Muus P, Babu S, Bedrosian CL, Cohen DJ, et al. Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney Int. 2015;87(5):1061–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, et al. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant. 2012;12(12):3337–54.

    Article  CAS  PubMed  Google Scholar 

  85. Zuber J, Fakhouri F, Roumenina LT, Loirat C, Frémeaux-Bacchi V, aHUS/C3G FSGf. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol. 2012;8(11):643–57.

    Article  CAS  PubMed  Google Scholar 

  86. Kello N, El Khoury L, Marder G, Furie R, Zapantis E, Horowitz DL. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature. In Seminars in arthritis and rheumatism: WB Saunders; 2018.

    Google Scholar 

  87. Sarno L, Tufano A, Maruotti GM, et al. J Nephrol. 2019;32:17. https://doi.org/10.1007/s40620-018-0517-z.

    Article  CAS  PubMed  Google Scholar 

  88. Bagon JA, Vernaeve H, De Muylder X, Lafontaine JJ, Martens J, Van Roost G. Pregnancy and dialysis. Am J Kidney Dis. 1998;31(5):756–65.

    Article  CAS  PubMed  Google Scholar 

  89. Mattos P, Santiago MB. Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature. Clin Rheumatol. 2012;31(6):897–905.

    Article  PubMed  Google Scholar 

  90. Campise M. Pregnancies in women receiving renal transplant for lupus nephritis: description of nine pregnancies and review of the literature. Lupus. 2015;24. SRC – GoogleScholar:1210–3.

    Article  CAS  PubMed  Google Scholar 

  91. Group KDIGOKTW. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–155.

    Google Scholar 

  92. Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013;27(3):435–47.

    Article  PubMed  Google Scholar 

  93. Campise M. Pregnancies in women receiving renal transplant for lupus nephritis: description of nine pregnancies and review of the literature. Lupus. 2015;24:1210–3.

    Article  CAS  PubMed  Google Scholar 

  94. McGrory CH. Pregnancy outcomes in female renal recipients: a comparison of systemic lupus erythematosus with other diagnoses. Am J Transplant. 2003;3:35–42.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA

    Nina Kello

  2. Department of Internal Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, NY, USA

    Jeanie Lee

  3. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, NY, USA

    Donandre Jackson

  4. Division of Rheumatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, NY, USA

    Galina Marder & Sonali Narain

Authors
  1. Nina Kello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeanie Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donandre Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Galina Marder
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sonali Narain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nina Kello .

Editor information

Editors and Affiliations

  1. Division of Kidney Diseases and Hypertension, Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, Great Neck, NY, USA

    Mala Sachdeva

  2. Division of Kidney Diseases and Hypertension, Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, Great Neck, NY, USA

    Ilene Miller

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kello, N., Lee, J., Jackson, D., Marder, G., Narain, S. (2020). Renal Manifestations in Lupus Pregnancy. In: Sachdeva, M., Miller, I. (eds) Obstetric and Gynecologic Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-25324-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25324-0_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25323-3

  • Online ISBN: 978-3-030-25324-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation